Esperance Pharmaceuticals, Inc.
Records under this name other than patents Esperance Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Esperance Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,255,134 | Lytic Domain Fusion Constructs and Methods of Making and Using Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,318,899 | Lytic Domain Fusion Constructs and Methods of Making and Using Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,546,535 | Lytic Domain Fusion Constructs and Methods of Making and Using Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,066,693 | Methods for diagnosing LHRH or hCG/LH receptor expressing tumors, cancers and neoplasias Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,729,740 | Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,586,996 | Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,093,961 | Methods for Diagnosis of and Predicting Treatment Efficacy of Hormone Receptor Expressing Tumors, Cancers and Neoplasias Formerly held In force · High confidence | In force | High confidence | |
| US 9,492,563 | Antibody/Drug Conjugates and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 10,233,214 | Antibody/Drug Conjugates and Methods of Use Formerly held In force · High confidence | In force | High confidence |